Press Releases Elutia Inc.

Equities

ELUT

US05479K1060

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-31 pm EDT			5-day change	1st Jan Change
3.25 ^USD	+0.93%		-.--%	+50.46%

May. 09	Elutia Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
May. 09	Earnings Flash (ELUT) ELUTIA Posts Q1 Revenue $6.7M, vs. Street Est of $6.1M	MT

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Elutia to Showcase BioEnvelope Product Line at Heart Rhythm 2024	May. 13	AQ
Elutia : Q1 2024 Financial Results Presentation	May. 09	PU
Elutia Announces First Quarter 2024 Results: SimpliDerm® Sales Increase 55%, CanGaroo®RM on Track for Second Quarter 2024 FDA Clearance	May. 09	AQ
Elutia to Report First Quarter 2024 Financial Results on Thursday, May 9, 2024	May. 02	AQ
Elutia Planet MicroCap Showcase: VEGAS 2024 Presentation	May. 02	PU
Elutia to Present at the Planet MicroCap Showcase: VEGAS 2024 on Wednesday, May 1	Apr. 24	AQ
Elutia Reports Fourth Quarter and Full Year 2023 Financial Results: Anticipates CanGarooRM® Clearance Decision in First Half of 2024	Mar. 07	AQ
Elutia to Report Fourth Quarter and Full Year 2023 Financial Results on Thursday, March 7, 2024	Feb. 22	AQ
Elutia's CanGarooRM: Pioneering Drug-Eluting Biologic for Secure Medical Implants	Feb. 20	AQ
Elutia Regains Compliance with Nasdaq Listing Requirements	Jan. 10	AQ
Elutia Submits CanGarooRM® Antibiotic-Eluting Biomatrix for FDA Clearance	Dec. 18	AQ
Elutia : The Wall Street Transcript	Dec. 04	PU
Elutia Reports 26% Year-Over-Year Sales Growth of Proprietary Products and Strengthened Balance Sheet in Third Quarter 2023 Financial Results	Nov. 13	AQ
Elutia Completes Divestiture of Orthobiologics Business Unit for Cash Proceeds of Up to $35 Million	Nov. 09	AQ
Elutia to Report Third Quarter 2023 Financial Results on Monday, November 13, 2023	Nov. 06	AQ
Aziyo Biologics Rebrands as Elutia to Reflect Strategic Focus on Drug Eluting Biomatrices	23-09-06	AQ
Aziyo Biologics Announces Publication of a CanGaroo® Case Study Demonstrating Bioenvelope Benefits for Reoperative Procedures	23-08-30	AQ
Aziyo Biologics : 2Q 2023 Financial Results Presentation	23-08-15	PU
Aziyo Biologics Reports Second Quarter 2023 Financial Results - Transformation Continues to Drug-Eluting Biomatrix Company	23-08-14	AQ
Aziyo Biologics to Report Second Quarter 2023 Financial Results on Monday, August 14, 2023	23-07-31	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Elutia Inc.

Equities

ELUT

US05479K1060

Press Releases

Filters